Pattern of local-regional recurrence in patient with early breast cancer after mastectomy: An analysis of 357 cases at King Chulalongkorn Memorial Hospital

Journal of the Medical Association of Thailand

Volumn 87, Issue SUPPL. 2, 2004, Pages

  Lertsanguansinchai, Prasert ^a   Lertbutsayanukul, Chawalit ^a   Chatamra, Kris ^a   Shotelersuk, Kanjana ^a   Voravud, Narin ^a   Khorprasert, Chonlakiet ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Early stage breast cancer; Local regional recurrence; Mastectomy

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; BREAST CANCER; CANCER STAGING; CLAVICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HORMONAL THERAPY; HOSPITAL; HUMAN; INCIDENCE; LUNG METASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; PATIENT REFERRAL; POSTOPERATIVE CARE; RECURRENCE RISK; RECURRENT DISEASE; RETROSPECTIVE STUDY; THORAX WALL;

ADULT; AGED; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; HUMANS; MASTECTOMY; MASTECTOMY, MODIFIED RADICAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; THAILAND;

EID: 22744437207     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. American Cancer Society. Cancer facts and figures 2003. Atlanta: American Cancer Society 2003.
2. Deerasamee S, Martin N, Sontipong S, et al. Cancer in Thailand 1992-1994; Vol II: 53-55 (IARC Scientific Publications No. 145), Lyon IARC.
3. Sriplung H, Sontipong S, Martin N, et al. Cancer in Thailand 1995-1997; Vol III: 47-8.
4. Tumor Registry Statistical Report 2001. King Chulalongkorn Memorial Hospital.
5. Early Breast Cancer Trialists' Collaborative Group. Polychemotherapy for early breast cancer: an overview of the randomized trials. Lancet 1998; 352: 930-42.
6. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomized Trials. Lancet 1998; 351: 1451-67.
7. Early Breast Cancer Trialists' Collaborative Group. Effect of radiotherapy and surgery in early breast cancer: an overview of the randomized trials. N Engl J Med 1995; 333: 1444-55.
8. Overgaard M, Hansen P, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 1997; 337: 949-55.
9. Ragaz J, Jackson S, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997; 337: 956-62.
10. American Joint Committee on Cancer. AJCC Cancer staging manual. Philadelphia: Lippincott-Raven, 1997; 171-8.
11. Fisher B, Perera F, Cooke AL, et al. Long term follow up of axillary node positive breast cancer patients receiving adjuvant systemic therapy alone: Pattern of recurrence. J Radiat Oncol Biol Phys 1997; 38: 541-50.
12. Hong Kong Cancer Registry. Cancer incidence and mortality in Hong Kong, 1993-1994:12.
13. Host H, Brennhovd I, Loeb M. Postoperative radiotherapy in breast cancer-long term results from the Oslo study. J Radiat Oncol Biol Phys 1986; 12: 727-32.
14. Tony S.K. Mok, Wing Hong Kwan, et al. Clinical outcomes of post-operative locoregional radiotherapy in pre-menopausal and post-menopausal Chinese women with breast cancer. Radiotherapy Oncol 2000; 54: 201-8
15. Fowble B, Gray R, Bilchrist K, et al. Identification of a subgroup of patients with breast cancer and higtologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy. J Clin Oncol 1988; 6: 1107-17.
16. Stefanik D, Goldberg R, Byrne P, et al. Localregional failure in patients treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 1985; 3: 660-5.
17. Sykes HF, Sim DA, Wong CJ, et al. Local-regional recurrence in breast cancer after mastectomy and adriamycin-based adjuvant chemotherapy. Evaluation of the role of postoperative radiotherapy. Int J Radiat Oncol Biol Phys 1989; 16: 671-7.
18. Bonadonna G, Valagussa P, Rossi A, et al. Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer. Breast Cancer Res Treat 1985; 5: 95-115.
19. Marks LB, Halperin EC, Prosnitz LR, et al. Postmastectomy radiotherapy following adjuvant chemotherapy and autologous bone marrow transplantation for breast cancer with greater than or equal to 10 positive axillary lymph nodes. Cancer and Leukemia Group B. Int J Radiat Oncol Biol Phys 1992; 23: 1021-6.
20. Fisher B, Redmond C, Fisher ER, et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985; 312: 674-81.
21. Wallgren A, Aruer O, Bergstrom J, et al. Radiation therapy in operable breast cancer. Results from the Stockholm trial on adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 1986; 12: 533-7.
22. Rutqvist LE, Cedermark B, Glas U, et al. Radiotherapy, Chemotherapy and tamoxifen as adjuncts to surgery in early breast cancer: A summary of three randomized trials. Int J Radiat Oncol Biol Phys 1989; 16: 629-39.
23. Overgaard M, Christensen JJ, Johansen H, et al. Evaluation of radiotherapy in high-risk breast cancer patients: Report form the Danish Breast Cancer Cooperative Group (DBCG 82) Trial. Int J Radiat Oncol Biol Phys 1990; 19: 1121-34.
24. Arriagada R, Erik L, Mattsson A, Kramer A, Rotstein S. Adequate locoregional treatment for early breast cancer may prevent secondary dissemnation. J Clin Oncol 1995; 13: 2869-78.
25. Kaija H, Maunu P. Tangential breast irradiation with or without internal mammary chain irradiation: results of a randomized trial. Radiotherapy Oncol. 1995; 36: 172-6.
26. Veronesi U, Cascinelli N, Greco M, et al. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg. 1985; 202: 701-7.
27. Arriagada R, Le MG, Mouriesse H, et al. Long term effect of internal mammary chain treatment Result of a multivariate analysis of 1195 patients with operable breast cancer and positive axillary nodes. Radiotherapy and Oncology 1988; 11: 213-22.
28. Handley RS. The conservative radical mastectomy of patey: 10 year results in 425 patients. Breast 1985; 2: 16-22.
29. Axelsson CK, Mouridsen HT, Zedeler K. Axillary dissection of level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG). Eur J Cancer 1992; 28A: 1415-8.
30. Kiricuta CI, Tansch J. A mathematical model of axillary lymph node involvement base on 1446 complete axillary dissection in patients with breast carcinoma. Cancer 1992; 69: 2496-501.
31. Blomqvist C, Tiusanen K, Elomaa I, et al. The combination of radiotherapy, adjuvant chemotherapy (cyclophosphamide-doxorubicin-ftorafur) and tamoxifen in stage II breast cancer. Long term follow-up results of a randomized trial. Br J Cancer 1992; 66: 1171-6.
32. National Comprehensive Cancer Network. Oncology practice Guidelines Volume 6, November 1999:187-212.